Results of intraoperative radiotherapy given as a boost after breast conserving-surgery
Author(s) -
Kraiwut Onthong,
Chakapong Chakkabat,
Chonnipa Nantavithya,
Kanjana Shotelersuk,
Sikrit Denariyakoon,
Mawin Vongsaisuwon,
Adhisabandh Chulakadabbav,
Kris Chatamra,
Kitwadee Saksornchai
Publication year - 2020
Publication title -
gland surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 22
eISSN - 2227-8575
pISSN - 2227-684X
DOI - 10.21037/gs-20-249
Subject(s) - medicine , cosmesis , breast conserving surgery , breast cancer , radiation therapy , surgery , clinical endpoint , external beam radiotherapy , radiology , cancer , mastectomy , brachytherapy , randomized controlled trial
Whole breast irradiation after breast-conserving surgery (BCS) with an external beam boost of 10-16 Gy is currently the standard treatment in breast cancer. Various modalities have been used for tumor bed boost irradiation. This study aimed to evaluate the local recurrence rate, overall survival rate (OSR), toxicity and cosmetic outcome of intraoperative radiotherapy (IORT) as a boost followed by whole breast irradiation in patients who received BCS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom